Reported results
- Net sales were $23.3 billion, an increase of 4.0% versus the prior year.
- Organic sales increased 4.0% versus the prior year.
- Diluted net earnings per share were $1.97, an increase of 1% versus the prior year.
- Core earnings per share were $2.00, an increase of 1% versus the prior year.
- Operating cash flow was $5.8 billion and net earnings were $4.8 billion for the quarter.
- Free cash flow productivity was 93%.
Guidance
- Fiscal 2027 all-in sales growth in the range of two to four percent versus the prior year.
- Fiscal 2027 organic sales growth in the range of one to three percent versus the prior year.
- Fiscal 2027 diluted net earnings per share growth in the range of one to five percent versus fiscal 2026 diluted net EPS of $6.62.
- Fiscal 2027 core earnings per share growth in the range of in-line to three percent versus fiscal 2026 core EPS of $6.89.
- Fiscal 2027 core effective tax rate in the range of 20% to 21%.
- Fiscal 2027 capital spending estimated to be in the range of four and a half to five and a half percent of net sales.
- Fiscal 2027 free cash flow productivity of 85% to 90%.
Notes
The Company expects to incur approximately $2 billion in before-tax restructuring costs over two years, with the remainder expected to be incurred in fiscal 2027.
Price and volatility reaction
The stock moved +5.6% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -1.4 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 156.84 | 2026-10-21 |
| Close after release | 165.59 | 2026-10-22 |
| Realised move | +5.6% | close to close |
| 30d ATM IV change | -1.4 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-22 (8-K, Item 2.02). Read the original filing on sec.gov.
